These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 30997488)
1. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity. Yadava RS; Kim YK; Mandal M; Mahadevan K; Gladman JT; Yu Q; Mahadevan MS Hum Mol Genet; 2019 Jul; 28(14):2330-2338. PubMed ID: 30997488 [TBL] [Abstract][Full Text] [Related]
2. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1). Gladman JT; Mandal M; Srinivasan V; Mahadevan MS PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817 [TBL] [Abstract][Full Text] [Related]
3. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development. Michel L; Huguet-Lachon A; Gourdon G PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785 [TBL] [Abstract][Full Text] [Related]
4. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I. Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287 [TBL] [Abstract][Full Text] [Related]
5. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA. Yadava RS; Yu Q; Mandal M; Rigo F; Bennett CF; Mahadevan MS Hum Mol Genet; 2020 Jun; 29(9):1440-1453. PubMed ID: 32242217 [TBL] [Abstract][Full Text] [Related]
6. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324 [TBL] [Abstract][Full Text] [Related]
7. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132 [TBL] [Abstract][Full Text] [Related]
8. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy. Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378 [TBL] [Abstract][Full Text] [Related]
9. Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise. Chamberlain CM; Ranum LP Hum Mol Genet; 2012 Nov; 21(21):4645-54. PubMed ID: 22846424 [TBL] [Abstract][Full Text] [Related]
11. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984 [TBL] [Abstract][Full Text] [Related]
12. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain. Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901 [TBL] [Abstract][Full Text] [Related]
13. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483 [TBL] [Abstract][Full Text] [Related]
14. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322 [TBL] [Abstract][Full Text] [Related]
16. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658 [TBL] [Abstract][Full Text] [Related]
18. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772 [TBL] [Abstract][Full Text] [Related]
19. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245 [TBL] [Abstract][Full Text] [Related]
20. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms. Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]